Novo Nordisk retains a strong market position in a high-growth industry, with P/E multiples poised to expand. See why NVO ...

The hitmaker, 50, was a guest on the show to promote his biopic Better Man, and during the interview, discussed the appearance of Jonno Davies, who plays his younger self.

Omega Therapeutics ( ($OMGA) ) has shared an announcement. Michelle C. Werner has resigned from Omega Therapeutics’ Board of Directors and the ...

A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...

Diabetes drugs now represent over 75% of total sales in the metabolic disorders market, up from below 40% ten years ago. The ...

The weight-loss market began feeling some growing pains as the year ended, creating more wariness for the upcoming year. For ...

We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on Kontra Investments’ Substack by Kontra. In this article, we ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

By itself, it’s not enough, but body mass index has years of evidence behind it and still has a place in clinical assessments ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20 percent of their body weight, on average, a result that caused the Danish company’s ...

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.